Similarly, KIT-regulated enhancer domain in GIST could be targeted by BRD4, a crucial activator of RNAPII transcription at active chromatin marks, and the BBIs can reverse the transcription abnormalities of targeted genes which are induced by BRD4 [67, 188]. Here, BRD4 is linked to gastrointestinal stromal tumor.